Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Weizhou Biotechnology is a specialized biotechnology service provider focused on single-cell sequencing and spatial multi-omics technologies. The company offers a comprehensive suite of services including single-cell RNA sequencing, spatial transcriptomics, and advanced bioinformatics analysis to support academic and pharmaceutical research. By leveraging platforms like 10x Genomics and Stereo-seq, Weizhou Biotech enables high-resolution mapping of cellular heterogeneity and tissue architecture. Their services are primarily utilized in oncology, immunology, and neuroscience to identify new biomarkers and therapeutic targets. The company aims to accelerate the transition from basic research to precision medicine through integrated multi-omic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Weizhou Biotechnology.